Meihua (NASDAQ: MHUA) updates timing of $15.2M private share placement

Rhea-AI Filing Summary

Meihua International Medical Technologies Co., Ltd. filed an amended report to correct clerical errors in an earlier description of its October 2025 private placement. The company had agreed to sell 40,000,000 ordinary shares at a purchase price of $0.38 per share for gross proceeds of $15.2 million to several non-U.S. purchasers under Regulation S.

According to the updated disclosure, the company issued 24,000,000 ordinary shares to these purchasers on October 17, and on January 20, 2026 it issued the remaining 160,000 class A ordinary shares, par value $0.05 per share, after a 100:1 split and adoption of a dual-class structure, completing the October offering. The company reports 857,914 issued and outstanding class A ordinary shares as of January 20, 2026.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K/A

REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE

SECURITIES EXCHANGE ACT OF 1934

For the Month of January 2026

Commission file number 001-41291

Meihua International Medical Technologies Co., Ltd.

(Translation of registrant’s name into English)

88 Tongda Road, Touqiao Town

Guangling District, Yangzhou, 225000

People’s Republic of China

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F  ☒        Form 40-F  ☐

 Explanatory Note

Meihua International Medical Technologies Co., Ltd. (the “Company”) is furnishing this Amendment on Form 6-K/A (this “Amendment”) to its current report on Form 6-K furnished on December 16, 2025 (the “Original 6-K”), solely to correct certain clerical errors in the description of the Company’s closing of a private placement offered in October 2025 (the “October Offering”). Specifically, this Amendment corrects references to closing date of the October Offering. The corrected disclosure is set forth below. Except as described in this explanatory note, this Amendment does not amend, modify, or update any other disclosures contained in the Original 6-K.

Closing of a Private Placement

As previously disclosed, Meihua International Medical Technologies Co., Ltd. (the “Company”) entered into a Securities Purchase Agreement with several “non-U.S. Persons” (the “October Purchasers”) as defined in Regulation S of the Securities Act of 1933, as amended (“the Securities Act”) on October 8, 2025 for a private placement (“October Offering”) of 40,000,000 ordinary shares of the Company, par value, $0.0005 per share, with the purchase price of $0.38 per share for the gross proceeds of $15.2 million. On October 17, the Company issued 24,000,000 ordinary shares to the October Purchasers. On January 20, 2026, the Company issued the remaining 160,000 class A ordinary shares, par value $0.05 per share (post-100:1-split and post-dual-class-structure) to the October Purchasers and the October Offering was fully closed. The Company has 857,914 issued and outstanding class A ordinary shares as of the date of this Amendment. 

1

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Meihua International Medical Technologies Co., Ltd.
By:	/s/ Leyi Lee
Name:	Leyi Lee
Title:	Chief Executive Officer
Date: January 20, 2026

2

FAQ

What did Meihua International Medical Technologies (MHUA) change in this Form 6-K/A?

The company corrected clerical errors in an earlier report about the closing of its October 2025 private placement, specifically updating the referenced closing date and providing the correct description of when shares were issued and when the offering was fully closed.

How large was Meihua International Medical Technologies' October 2025 private placement?

The private placement covered 40,000,000 ordinary shares of Meihua International Medical Technologies Co., Ltd. at a purchase price of $0.38 per share, for total gross proceeds of $15.2 million.

When did Meihua International Medical Technologies issue the shares in the October offering?

The company issued 24,000,000 ordinary shares to the October purchasers on October 17, and on January 20, 2026 it issued the remaining 160,000 class A ordinary shares, after which the October offering was fully closed.

Who participated in Meihua International Medical Technologies' October 2025 offering?

The securities purchase agreement was entered into with several “non-U.S. Persons” as defined in Regulation S under the Securities Act of 1933, referred to as the October purchasers.

How many class A ordinary shares of Meihua International Medical Technologies are outstanding now?

The company reports 857,914 issued and outstanding class A ordinary shares as of the date of the amendment, which is January 20, 2026.

What share structure changes are referenced in Meihua International Medical Technologies' amendment?

The amendment notes that the 160,000 class A ordinary shares issued on January 20, 2026 are described as post-100:1 split and post-dual-class-structure, indicating that a stock split and dual-class share structure were in place by that time.